A consortium made up of a group of private and public companies work together to develop the 4D-Bioskin project. Within this group of companies are Biorem, the pharmaceutical company Reig Jofre, University of Barcelona and the Vall d’Hebron Research Institute (VHIR), all members of CATALONIA.HEALTH.

The company specialized in visual and cognitive improvement WIVI Vision, member of CATALONIA.HEALTH, has won the 4th prize in the welfare sector in the first edition of the Impact Social Cup (ISC). It is a competition made up of 8 sectors of large economic activities where entrepreneurs, companies and people highlight their positive impact on society. 

The technology centre Eurecat, a member of CATALONIA.HEALTH, together with the SJD Barcelona Children's Hospital, have designed a social desktop robot, called Robot Jana, to help palliative pediatric patients at home, as it allows remote monitoring of the patient's symptoms and facilitates communication between professionals and the family.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, continues its international growth strategy with the opening of a new subsidiary in the Czech Republic, where it already operates through distribution agreements. The new subsidiary will have a sales team specialized in the pharmaceutical market and with the collaboration of a local partner (LERAM Pharma).

The biopharmaceutical AbilityPharma, a member of CATALONIA.HEALTH, has published in BMC Cancer the final data of its phase 1/2 ENDOLUNG trial that evaluates the drug IBRILATAZAR (ABTL0812) in combination with chemotherapy for patients with advanced or recurrent endometrial cancer.

The PERSAM project of IQS, a member of CATALONIA.HEALTH, obtains funding in the program of Knowledge Industry Grants – LLAVOR modality of the AGAUR, an organism of the Generalitat of Catalonia. PERSAM is dedicated to the development of a flexible breathing biosensor for the prevention and monitoring of liver diseases.

Oxolife, member of CATALONIA.HEALTH, has successfully presented the promising results of its Phase 2 study of its new OXO-001 research drug at the 40th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in Amsterdam.   

This August the new government of the Generalitat of Catalonia has been appointed. Two of the new government’s departments will be led by members of CATALONIA.HEALTH. They are Dr. Núria Montserrat, principal investigator and deputy director of translation at the Institute for Bioengineering of Catalonia (IBEC), and Dr. Olga Pané, former manager at Hospital del Mar. 

Integra Therapeutics, member of CATALONIA.HEALTH, will receive a grant of 2.5 million euros and equity investment of up to 8 million euros from the European Commission via the European Innovation Council (EIC) Accelerator program

AbilityPharma, member of CATALONIA.HEALTH, announces a strategic collaboration with AGC Pharma Chemicals, a company specialized and dedicated to the International Contract Development and Manufacturing Organization (CDMO).  

Trifermed, member of CATALONIA.HEALTH, announces the 8th edition of the Trifermed Awards for Social Impact in Healthcare. This prestigious event, founded by professor and doctor Sergi X. Trilla, will take place on September 17th in Barcelona.

The association, a recognised hub of the health and life sciences ecosystem in Catalonia, presents the new name to respond to its transversality, shaped by the great diversity of agents in the sector that make it up.

On 12 and 13 of June, ACESABIO members, of which CATALONIA.HEALTH is a member, met in Vigo at the Galicia Biodays event to discuss the impact of clusters on the development of business competitiveness.

The Center for Comparative Medicine and Bioimage of Catalonia (CMCiB), a strategic project of Germans Trias i Pujol Research Institute (IGTP), member of CATALONIA.HEALTH, celebrates five years since its launch with the event "CMCiB Symposium: 5 years Enabling Pioneering Biomedical Research".

Oxolife, member of CataloniaBio & HealthTech, presented at the 40th ESHRE annual meeting in Amsterdam the research that shows the efficacy of a non-hormonal oral drug that increases the rate of embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Asabys Partners, member of CataloniaBio & HealthTec, leads and invests in the first round of funding from its new Sabadell Asabys II fund, where Augustine Therapeutics is able to raise a total of 17 million euros. The pharmaceutical company Eli Lilly & Company and the Charcot-Marie-Tooth Research Foundation (CMT) have also participated in this round, as well as existing investors from the company. 

HIPRA, member of CataloniaBio & HealthTech, was visited by a team from HERA (Health Emergency Preparedness and Response) management department, the European Commission authority that strives to prevent, detect and respond quickly to health emergencies in the European Union. 

DevsHealth and Germans Trias i Pujol Research Institute (IGTP), both members of CataloniaBio & HealthTech, have announced a new collaboration to develop new antibiotics for multi-resistant Staphylococcus aureus infections.

Nanomol Technologies, member of CataloniaBio & Healthtech, obtains the authorization of the Spanish Agency for Medicines and Health Products (AEMPS) as a pharmaceutical laboratory for the control of physicochemical quality of medicines for human, veterinary use and in research. 

Mitelos, member of CataloniaBio & HealthTech, has announced its expansion into six new markets: Perú, the United Kingdom, Ireland, New Zealand, Finland, and Iceland. This strategic move marks a significant step forward in the company’s mission to make its products available to doctors, pharmacists and patients.